Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
This study has been completed.
Study NCT01023958   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: November 24, 2009   Last Updated: February 8, 2012   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)